Oculis Holding AG

OCS NASDAQ Santé & Biotech Europe CH1242303498
11.61 $
4.69 %

Oculis Holding AG est une entreprise de biotechnologie focalisée sur le développement de traitements ophtalmologiques pour améliorer la vision.

Performance & Momentum

6 Months 45.82 %
1 Year 41.69 %
3 Years 3.57 %
5 Years 14.33 %

Similar stocks to Oculis Holding AG

Anantys Community

Be the first to share your analysis on Oculis Holding AG.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases